NCAM1 and inflammatory bowel disease: Cellular response to vitamin D was among the top hits of negatively enriched GO terms in non-inflamed CD patients compared to healthy controls in a study with treatment-naive IBD patients and their mucosal gene expression, thus, strengthening the body of evidence regarding vitamin D as a significant actor in the pathogenesis of CD56,57.